Ohio State Wexner Medical Center

According to the video, two medications are currently FDA-approved in the United States for treating obesity or overweight in people who also have medical conditions such as high blood pressure, sleep apnea, or abnormal cholesterol.

1. 0:00 Introduction
2. 0:04 Medication Names
3. 0:41 Interchangeability
4. 1:01 Eligibility and Indications
5. 1:34 Consulting Your Doctor

• Who is speaking: Clinician

In this short Ohio State Wexner Medical Center video, a clinician talks about how quickly people lose weight while taking a GLP-1 receptor agonist medication. The speaker says patients raise the question for different reasons.

1. 0:00 Introduction to GLP-1
2. 0:23 Healthy weight loss rates
3. 0:36 Importance of medical guidance
4. 0:58 Risks of rapid weight loss

• Who is speaking: Clinician

In this short video from Ohio State Wexner Medical Center, a clinician explains what a GLP-1 receptor agonist is and how it works. According to the video, the medication mimics the GLP-1 peptide, a hormone the body makes naturally.

1. 0:00 Introduction to GLP-1
2. 0:35 Mechanisms and Benefits
3. 1:21 Conclusion

• Who is speaking: Clinician

In this short Ohio State Wexner Medical Center video, a clinician in obesity medicine talks about maintenance doses of GLP-1 receptor agonist medications.

1. 0:00 Introduction to maintenance
2. 1:04 Specific medication dosages
3. 1:18 Weight regain risks

• Who is speaking: Clinician

In this short clip from Ohio State Wexner Medical Center, a clinician talks about weight regain after stopping GLP-1 medications.

1. 0:00 Weight regain data
2. 0:31 Importance of lifestyle
3. 1:03 Comprehensive support program

• Who is speaking: Clinician

In this short Ohio State Wexner Medical Center video, a clinician describes natural options for managing some of the side effects of GLP-1 receptor agonist therapy.

• Side effects mentioned: constipation
• Who is speaking: Clinician